Low-water content acrylate-acrylamide copolymers for ophthalmic devices

Patent metadata

Field	Value
Publication number	US-9921341-B2
Application number	US-201514967760-A
Country	US
Kind code	B2
Filing date	Dec 14, 2015
Priority date	Dec 16, 2014
Publication date	Mar 20, 2018
Grant date	Mar 20, 2018

Abstract

Acrylate-acrylamide copolymers are disclosed. They are rigid and glassy in dry state at room temperature (from about 23° C. to about 28° C.), but are soft and very deformable and have a high refractive index, a high glistening resistance and a low aging-related surface light scattering in fully hydrated state. They are particularly suitable for making wet-packed intraocular lenses (IOLs) which can be delivered through sub 2.0 mm incisions.

First claim

We claim:

1. A polymeric ophthalmic device material, having: (1) a glass transition temperature of from about 28° C. to about 40° C. in a dry state; (2) a glass transition temperature of about 20° C. or lower in a fully hydrated state; (3) a refractive index of greater than 1.50 measured at 589 nm and at 23±3° C. in the fully hydrated state; (4) an equilibrium water content of from about 5% to 11% by weight at a temperature of from 16° C. to 45° C.; (5) a glistening resistance characterized by having no bright field microvacuole and about 10 or less microvacuoles per viewing screen in glistering tests; (5) a Young's modulus of from about 5.0 MPa to 35.0 MPa; and (6) a 100% secant modulus of less than 5.0 MPa,
wherein the ophthalmic device material is a polymerization product of a polymerizable composition selected from the group consisting of composition A1, composition A2, and composition A3,
wherein composition A1 comprises (a1) from about 18% to about 32% by weight of N,N-dimethylacrylamide, (b1) at least one hydrophobic acrylamido component selected from the group consisting of N-butyl acrylamide, N-butoxymethyl acrylamide, and N-methoxypropyl acrylamide, (c1) from about 40% to about 76% by weight of said one or more aryl acrylic monomers of formula (I)

wherein A 1 is H or CH 3 ; B 1 is (CH 2 ) m1 or [O(CH 2 ) 2 ] Z1 in which m1 is 2-6 and z1 is 1-10; Y 1 is a direct bond, O, S, or NR′ in which R′ is H, CH 3 , C n′ H 2n′+1 in which n′=1-10, iso-OC 3 H 7 , C 6 H 5 , or CH 2 C 6 H 5 ; W1 is 0-6, provided that m1+w1≤8; and D 1 is H, Cl, Br, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 6 H 5 , or CH 2 C 6 H 5 ,

(d1) from about 0.4% to about 2.5% by weight of at least one first polymerizable crosslinking agent,
wherein composition A2 comprises (a2) from about 15% to about 35% by weight of N-methylacrylamide, (b2) from about 0.4% to about 2.5% by weight of at least one second polymerizable crosslinking agent, (c2) from about 60% to about 80% by weight of one or more aryl acrylic monomers of formula (I) as defined above,
wherein composition A3 comprises (a3) from about 10% to about 35% by weight of a mixture of N,N-dimethylacrylamide and N-hydroxyethylacrylamide, (b3) from about 0.4% to about 2.5% by weight of at least one third polymerizable crosslinking agent, (c3) from about 60% to about 80% by weight of one or more aryl acrylic monomers of formula (I) as defined above,
wherein the first, second, and third polymerizable crosslinking agents are selected from the group consisting of ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, allyl methacrylate, 1,3-propanediol dimethacrylate, 2,3-propanediol dimethacrylate, 1,6-hexanediol dimethacrylate, 1,4-butanediol dimethacrylate, ethylene glycol diacrylate, diethylene glycol diacrylate, triethylene glycol diacrylate, tetraethylene glycol diacrylate, allyl acrylate, 1,3-propanediol diacrylate, 2,3-propanediol diacrylate, 1,6-hexanediol diacrylate, 1,4-butanediol diacrylate, N,N′-hexamethylene bismethacrylamide, N,N′-dihydroxyethylene bisacrylamide, N,N′-dihydroxyethylene bismethacrylamide, N,N′-methylene bisacrylamide, and N,N′-methylene bismethacrylamide.

2. The ophthalmic device material of claim 1 , wherein the device material in the fully hydrated state has an elongation at break of greater than 90%.

3. The ophthalmic device material of claim 2 , wherein the device material in the fully hydrated state has a surface light scattering of about 30 CCT or less after 10-years accelerated aging (90° C., 81 days in a balanced salt solution).

4. The ophthalmic device material of claim 3 , wherein the device material in the fully hydrated state remains substantially clear when being heated from 23° C. to 35° C.

5. The ophthalmic device material of claim 4 , wherein in formula (I), B 1 is (CH 2 ) m1 , m1 is 2-5, Y 1 is nothing or O, w1 is 0 or 1, and D 1 is H.

6. The ophthalmic device material of claim 4 , wherein said one or more aryl acrylic monomers of formula (I) are: 2-ethylphenoxy acrylate; 2-ethylphenoxy methacrylate; phenyl acrylate; phenyl methacrylate; benzyl acrylate; benzyl methacrylate; 2-phenylethyl acrylate; 2-phenylethyl methacrylate; 3-phenylpropyl acrylate; 3-phenylpropyl methacrylate; 4-phenylbutyl acrylate; 4-phenylbutyl methacrylate; 4-methylphenyl acrylate; 4-methylphenyl methacrylate; 4-methylbenzyl acrylate; 4-methylbenzyl methacrylate; 2-2-methylphenylethyl acrylate; 2,2-methylphenylethyl methacrylate; 2,3-methylphenylethyl acrylate; 2,3-methylphenylethyl methacrylate; 2,4-methylphenylethyl acrylate; 2,4-methylphenylethyl methacrylate; 2-(4-propylphenyl)ethyl acrylate; 2-(4-propylphenyl)ethyl methacrylate; 2-(4-(1-methylethyl)phenyl)ethyl acrylate; 2-(4-(1-methylethyl)phenyl)ethyl methacrylate; 2-(4-methoxyphenyl)ethyl acrylate; 2-(4-methoxyphenyl)ethyl methacrylate; 2-(4-cyclohexylphenyl)ethyl acrylate; 2-(4-cyclohexylphenyl)ethyl methacrylate; 2-(2-chlorophenyl)ethyl acrylate; 2-(2-chlorophenyl)ethyl methacrylate; 2-(3-chlorophenyl)ethyl acrylate; 2-(3-chlorophenyl)ethyl methacrylate; 2-(4-chlorophenyl)ethyl acrylate; 2-(4-chlorophenyl)ethyl methacrylate; 2-(4-bromophenyl)ethyl acrylate; 2-(4-bromophenyl)ethyl methacrylate; 2-(3-phenylphenyl)ethyl acrylate; 2-(3-phenylphenyl)ethyl methacrylate; 2-(4-phenylphenyl)ethyl acrylate; 2-(4-phenylphenyl)ethyl methacrylate; 2-(4-benzylphenyl)ethyl acrylate; 2-(4-benzylphenyl)ethyl methacrylate; 2-(phenylthio)ethyl acrylate; 2-(phenylthio)ethyl methacrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-benzyloxyethyl methacrylate; 3-benzyloxypropyl methacrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl methacrylate; or combinations thereof.

7. The ophthalmic device material of claim 4 , wherein said one or more aryl acrylic monomers are: 2-phenylethyl acrylate; 3-phenylpropyl acrylate; 4-phenylbutyl acrylate; 5-phenylpentyl acrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; or combinations thereof.

8. The ophthalmic device material of claim 7 , wherein the polymerizable composition is composition A1.

9. The ophthalmic device material of claim 8 , wherein the polymerizable composition further comprises at least one component selected from the group consisting of:
(i) from about 5% to about 15% by weight of hydroxyethyl methacrylate;
(ii) from about 1% to about 5% by weight of a poly(ethylene glycol)-containing polymerizable component of formula (II),

wherein: A 2 is H or CH 3 ; Q 2 and Q 2 ′ independent of each other are a direct bond, O, NH, or C(═O)NHCH 2 CH 2 O; X 2 and X 2 ′ independent of each other are a direct bond, O, NH, OC(═O)NH, or NHC(═O)NH; R 2 and R 2 ′ independent of each other are a direct bond, or (CH 2 ) p ; p=1-3; G 2 is H, C 1 -C 4 alkyl, (CH 2 ) m2 NH 2 , (CH 2 ) m2 CO 2 H, or R 2′ —X 2 ′-Q 2 ′-C(═O)CA 2 =CH 2 ; m2=2-6; and n2=45-225 when G=H, C 1 -C 4 alkyl, (CH 2 ) m2 NH 2 , or (CH 2 ) m2 CO 2 H; otherwise, n2=51-225;

(iii) a polymerizable UV-absorbing agent; and
(iv) a combination thereof.

10. The ophthalmic device material of claim 9 , wherein the poly(ethylene glycol)-containing polymerizable component of formula (II) has a number average molecular weight of 2,000-10,000 Daltons.

11. The ophthalmic device material of claim 7 , wherein the polymerizable composition is composition A2

Assignees

• Novartis Ag

Inventors

• Laredo Walter
• Akinay Ali E
• Jiang Xuwei
• Jinkerson David
• Nguyen Vincent
• Schlueter Douglas

Classifications

• A61L27/52

  Hydrogels or hydrocolloids · CPC title

• A61L2430/16

  for reconstruction of eye parts, e.g. intraocular lens, cornea · CPC title

• A61L27/26 Primary

  Mixtures of macromolecular compounds · CPC title

• G02B1/041

  Lenses · CPC title

• A61L27/50

  Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title